Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 45
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
8/10/2007
1.
Phase III Master Protocol for Randomized Comparison of Single-agent Chemotherapy vs Standard Therapy with CAF (CTX/DOX/5-FU) in Previously Untreated Patients with Stage IV Breast Carcinoma --- Amonafide and Other Phase II Agents
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
16 to physiologic 70
NCI
CLB-8642
CALGB-8642
2.
Study of Individualized Amonafide to Treat Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Completed
18 and over
Pharmaceutical / Industry
0001A2-200-US
NCT00087854
Last Modified:
5/1/1988
3.
Phase II Chemotherapy with Amonafide for Patients with Stage III or IV non-Small Cell Lung Cancer (Summary Last Modified 05/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
MSKCC-8739
NCI-T87-0098C, T87-0098
Last Modified:
10/1/1987
4.
Phase II Chemotherapy with Intravenous Amonafide in Patients with Extensive Small Cell Lung Cancer (Summary Last Modified 10/87)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
CAN-NCIC-IND42
NCI-T87-0137O, T87-0137, IND42
Last Modified:
2/1/1989
5.
Phase II Chemotherapy with Amonafide in Patients with Unresectable or Metastatic Pancreatic Cancer (Summary Last Modified 02/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UCCRC-5019
NCI-T87-0149O, T87-0149
Last Modified:
4/1/1988
6.
Phase II Chemotherapy with Amonafide in Patients with Renal Cell Carcinoma (Summary Last Modified 04/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
SWOG-8716
Last Modified:
10/15/2007
7.
Phase II Chemotherapy with Amonafide in Patients with Adenocarcinoma of the Prostate
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-8722
Last Modified:
12/1/1987
8.
Phase II Chemotherapy with Amonafide in Patients with Colorectal Carcinoma (Summary Last Modified 12/87)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
no age specified
NCI
SWOG-8714
Last Modified:
2/1/1989
9.
Phase II Chemotherapy with Amonafide in Patients with Pancreatic Adenocarcinoma (Summary Last Modified 02/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
SWOG-8720
Last Modified:
2/1/1992
10.
Phase II Chemotherapy with Amonafide in Patients with Advanced Hormone-Resistant Cancer of the Prostate (Summary Last Modified 02/92)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
18 and over
NCI
ICC-87U2
NCI-T87-0152D, T87-0152
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute